Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
International Journal of Obesity
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
July 2000, Volume 24, Number 7, Pages 915-919
Table of contents    Previous  Article  Next   [PDF]
Paper
Lymphocyte glucocorticoid receptor mRNA correlates negatively to serum leptin in normal weight subjects
C G Øgard, P Bratholm, L Ø Kristensen, T Almdal and N J Christensen

Division of Endocrinology, Herlev Hospital, University of Copenhagen, Denmark

Correspondence to: N J Christensen, Division of Endocrinology, Herlev Hospital, University of Copenhagen, 2730 Herlev, Denmark. nielsjue@post4.tele.dk

Abstract

OBJECTIVE: The aim of the present study was to test the hypothesis that glucocorticoid receptor mRNA concentrations decreased with increasing fatness in normal subjects.

MEASUREMENTS: Serum leptin concentrations, fat distribution parameters, lymphocyte glucocorticoid (GCR) mRNA, beta2-adrenoceptor mRNA and c-fos mRNA concentrations measured by RT-PCR-HPLC.

SUBJECTS: Fifteen healthy non-obese young subjects with a mean body mass index (BMI) of 23.5±0.3 (±s.e.m.) kg/m2.

RESULTS: Lymphocyte GCR and beta2-adrenoceptor mRNA concentrations averaged 4.2±0.2 (±s.e.m.) amol/mug total RNA and 1.4±0.1 amol/mug total RNA, respectively. There was a significant negative correlation between serum leptin and lymphocyte GCR mRNA (P<0.01). Serum leptin correlated positively with the waist-hip ratio (P<0.03), whereas lymphocyte GCR mRNA correlated negatively to the waist-hip ratio (P<0.04). Serum cortisol correlated with the weight of the subjects but not the waist-hip ratio or GCR mRNA.

CONCLUSIONS: It is suggested that the decrease in lymphocyte GCR mRNA concentration with increasing serum leptin concentrations is a counterregulatory response to an increased body fat content. Further studies are warranted, especially to elucidate the relationship between GCR mRNA in lymphocytes and in fat cells and to clarify the mechanism of the decrease in GCR mRNA.

International Journal of Obesity (2000) 24, 915-919

Keywords

fat; glucocorticoid receptor mRNA; leptin; lymphocytes

Introduction

Cortisol and leptin play a major role in the regulation of body weight. Hyper- and hypocortisolism are associated with obesity and weight loss, respectively. Leptin decreases body weight.1,2 Leptin and cortisol have therefore opposite effects on body weight regulation. We tested the hypothesis that the cellular response to cortisol is downregulated with increasing leptin concentrations. The glucocorticoid receptor (GCR) mRNA concentration was measured by reverse transcription-polymerase chain reaction-high pressure liquid chromatography (RT-PCR-HPLC). We primarily studied lymphocytes from normal subjects with different degrees of fatness to avoid secondary changes due to obesity. The relative fat mass was evaluated from the body mass index (BMI), the waist-hip ratio and serum leptin concentrations.3 The c-fos mRNA was measured to examine a possible effect of cytokines on the lymphocyte GCR concentration.

Subjects and methods

Subjects and protocol

The protocol was approved by the local Ethics committee. Fifteen healthy non-obese male subjects with a mean age of 33.3 y (range 24-48 y) were investigated after they had given informed written consent. The BMI ranged from 21.9 to 25.1 kg/m2 and averaged 23.5.±0.3 (±s.e.m.) kg/m2. The subjects fasted overnight and arrived in the laboratory at 08:00 h. They rested in the sitting position for 30 min. Thereafter a blood sample was obtained from an antecubital vein.

The following parameters were recorded or measured: age (y), weight (kg), height (cm), BMI (body weight in kg/(height in m)2), the waist-hip ratio, serum cortisol and leptin. GCR, beta2-adrenoceptor and c-fos mRNA concentrations were measured by RT-PCR and HPLC for separation of standard and unknown and for quantification.4,5

Isolation of lymphocytes

Blood for isolation of lymphocytes was sampled in tubes with EDTA as anticoagulant: mononuclear cells mainly lymphocytes were isolated by density centrifugation on LymphoprepÔ (Nycomed Pharma, Oslo, Norway). Initially blood was layered on LymphoprepÔ and centrifuged for 30 min at 1400 rpm (394 g) and 21°C. Lymphocytes were isolated and washed three times in RPMI 1640 medium with Hepes buffer (Life Technologies, Denmark) with bovine serum albumin (0.5%) at 4°C. Erythrocytes and 99% of the thrombocytes were removed by the isolation procedure. The lymphocyte cell concentration was adjusted to 5´106 cells per tube and resuspended in isotonic NaCl. Samples were then centrifuged, drained and frozen in liquid nitrogen and stored at -80°C.

Quantification of the GCR, beta2-adrenoceptor and c-fos mRNA in lymphocytes

mRNA in lymphocytes was quantified by RT-PCR and HPLC. The technique has been described in detail elsewhere.4,5

Primers and the construction of internal standard

The oligonucleotide primers were synthesized at DNA Technology (Aarhus, Denmark). For quantification of GCR mRNA we used the following primers, which did not distinguish between differentially spliced alpha/alpha2 and beta transcripts (U01351): 5' primer¾CAG-CAGGCCACTACAGGAGT (no. 1997-2016), and 3' primer¾CCCAGAGCAAATGCCATAAG (no. 2322-2303).

For quantification of beta2-adrenoceptor mRNA we used the following primers (M15169): 5' primer¾CGCTTCCATGTCCAGAACCT (no. 2302-2321), and 3' primer¾CTGTTCCACGTGATATCCAC (no. 2697-2678).

For quantification of c-fos mRNA we used the following primers (V01512): 5' primer¾GGC-TTCAACGCAGACTACGAGG (no. 301-322); and 3' primer¾CTCCTGTCATGGTCTTCACAACG (no. 1393-1371).

An internal standard DNA for the GCR mRNA, beta2-adrenoceptor mRNA and c-fos mRNA was constructed using the above-mentioned two sets of primers and the PCR-MIMICÔ construction kit from Clontech. The size of the internal standard was designed to be 596 bp for the GCR internal standard, 240 bp for the beta2-adrenoceptor internal standard and 601 bp for the c-fos internal standard.

An internal standard RNA for the GCR mRNA, the beta2-adrenoceptor mRNA and the c-fos mRNA was constructed mainly as described by Faure et al.6 The resulting internal standard RNA was quantified by UV-detection (Gene-Quant II, Pharmacia, Sweden). The resulting RT-PCR products were indistinguishable from the internal standard DNA.

The GCR primers mentioned above did not distinguish between the predominant alpha/alpha2 transcripts and the beta-transcript of the GCR-mRNA formed by differential splicing. We therefore also evaluated our results using a set of primers specific to the alpha/alpha2 form (U01351): 5' primer¾GTATTG AATTCCCCGAGATG (no. 2733-2752); and 3' primer¾ACAGACTTTGGGCACTGG (no. 3158-3141).

Isolation of RNA and determination of total RNA and DNA

RNA was isolated from lymphocytes using the RNeasy blood kit from Qiagen (Gmbh). After the lysis step 20 mul were removed for the determination of DNA. Elution was with DEPC-H2O at a concentration of 107 mononuclear cells per ml. 70 mmu mul were used for measuring the total RNA concentration by a Pharmacia Gene-Quant II.

The DNA concentration was measured by H33258 fluorescence (DyNAQuant 200 apparatus, Hoefer Pharmacia Biotech).

Reverse transcription

Before reverse transcription the RNA was treated with 1 IU RQ1 RNAse-free DNAse (Promega) for 15 min at 37°C. The DNAse was subsequently heat-inactivated by incubation at 60°C for 5 min. The reverse transcription mixture contained: RNA from 105 lymphocytes; internal standard RNA (see Table 1); 225 pmol 3'-primer; 1 mM of each dNTP, 60 U MMLV-RT (Promega), and 40 U RNA-guard in 25 mul Promega RT-buffer (50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2, 10 mM DTT). Incubation was at 37°C for 60 min, and the cDNA was stored frozen at -80°C or used immediately.

PCR

For the PCR reactions 3 mul cDNA aliquots were combined with 40 pmol of each primer, 150 muM of each dNTP, 0.2 U Taq polymerase (Pharmacia) in the supplied PCR reaction buffer, at 0°C in a volume of 100 mul, and overlayered with mineral oil. The amplification took place in a Perkin Elmer Model 480 thermocycler: after initial denaturation at 95°C for 2 min the reactions were cycled through 27 cycles consisting of 94°C for 45 s, annealing (Table 1) for 45 s and 72°C for 90 s. After the last cycle the incubation continued for 5 min, whereupon the temperature was lowered to 4°C. The PCR products were either used for HPLC immediately or stored frozen at -80°C.

Quantification of PCR products by HPLC

The HPLC system consisted of a TSKÒ DEAE-NPR column (4.6 mm i.d.´ 35 mm, with a short guard column), thermostated at 30°C. The mobile phase was a gradient: Buffer A¾25 mM Tris-HCl, pH 9.0, 1.0 M NaCl; buffer B¾25 mM Tris-HCl, pH 9.0. The gradient was from 25% to 54% A in 0.5 min, 54% to 59% A in 6.5 min, 59% to 70% A in 0.5 min, 70% A for 1.0 min, 70% to 25% A in 0.5 min, 25% A in at least 3.0 min, all with a flow of 1.0 ml/min. The pump was a Waters Model 616 gradient pump controlled by MillenniumÒ 32 software, which was also applied for data acquisition and processing. Detection was by an Applied Biosystems Model 759A UV-detector at 254 nm.

Ninety microliters were injected by a manual injector. The PCR product was quantified relative to the internal standard using areas and corrected for the different sizes of the two products. mRNA concentrations are expressed relative to the total (RNeasy) RNA content of the samples as amol mRNA/mug total RNA.

Validation of the technique

The amplification rate was exponential up to at least 27 cycles for both standard and unknown. The amplification was close to the theoretical rate of 2n (n=number of cycles) which can be obtained. The standard curve was linear, provided the ratio of the cDNA/standard area was between 0.5 and 4. When the calculated ratio exceeded this limit the sample was reanalysed with a reduced amount of mRNA added to RT.

Controls with no RT and no cDNA were run frequently. No contamination of sample mRNA with genomic DNA was observed.

The sequence of the PCR-products were confirmed by dideoxy-sequencing using the Perkin-Elmer dRhodamine Terminator Cycle Sequencing Chemistry and an ABI 310 Applied Systems apparatus for separation and fluorescence detection.

The sensitivity of the assay was approximately 0.004 amol RNA corresponding to 5000 muAU's.

Reproducibility. The Intra-assay coefficients of variations for the whole procedure (isolation of mRNA, RT and PCR) were 8.7% for the GCR receptor mRNA and 17% for the beta2-adrenoceptor mRNA. The PCR procedure alone showed consistently a high degree of reproducibility (coefficient of variation=6%).

Measurements of serum cortisol and leptin

Serum leptin and cortisol were measured by radioimmunoassay. The cortisol assay was purchased from Diagnostic Systems Laboratories, Texas, USA. The intra-assay coefficient of variation was 6.1% for a serum cortisol value in the normal range. The human leptin RIA kit was purchased from DRG Instruments, Marburg, Germany. The intrassay coefficient of variation was 5.3% for a serum leptin value in the normal range.

Statistics

Correlations were performed using the Spearman Test (Rs). Linear regression (r) was also performed. Multiple regression analysis and backward stepwise regression were performed by the SigmaStat programme version 1.02. A P value <0.05 was considered significant.

Results

Pertinent clinical data are presented in Table 2. Table 3 shows serum concentrations of cortisol and leptin. Plasma cortisol correlated negatively to the age of the subjects (Rs=-0.55; P<0.04) and positively to body weight (Rs=0.58; P<0.02). Plasma cortisol was not correlated to the GCR mRNA concentration, plasma leptin or to fatness distribution parameters (waist-hip ratio or BMI).

Figure 1 shows the negative correlation observed between serum leptin and the lymphocyte GCR receptor mRNA concentration (Rs=-0.63; P<0.01). Serum leptin correlated positively to the waist-hip ratio (Rs=0.57; P<0.03), whereas there was a negative correlation between the waist-hip ratio and the lymphocyte GCR mRNA concentration (Rs=-0.54; P<0.04; Figure 2). Stepwise regression analysis indicated that the GCR mRNA concentrations could be predicted from serum leptin concentrations (P<0.02), whereas the waist-hip ratio did not significantly add to the ability of the equation to predict the GCR mRNA values. The waist-hip ratio correlated best to the serum leptin concentrations. Neither serum leptin nor lymphocyte GCR mRNA concentration were correlated to the weight of the subjects or to BMI.

Lymphocyte beta2-adrenoceptor mRNA concentration averaged 1.4±0.1 amol/mug total RNA (Table 3). There was no correlation between beta2-adrenoceptor mRNA and the GCR mRNA concentration, body weight or fatness distribution parameters.

The lymphocyte GCR transcripts of the alpha/alpha2/beta and the alpha/alpha2 forms were studied in all subjects. No standard for the alpha/alpha2 form was prepared. The ratio between the two transcripts was 1.60±0.05. This value was based on the measured areas corrected for the different sizes of the two products and the total RNA concentration. The ratio was not correlated to the leptin concentration or the waist-hip ratio. There was a significant correlation between the two transcripts (r=0.89, P<0.001). The alpha/alpha2 transcript was also correlated to the waist-hip ratio (Rs=-0.64, P<0.012) and to the serum leptin concentration (Rs=-0.57, P<0.03). The c-fos mRNA concentration was much greater than the receptor mRNA concentrations (Table 3). There was no correlation between c-fos mRNA and serum leptin or GCR mRNA.

Discussion

The new finding in the present study is the relationship observed between lymphocyte GCR mRNA concentration and serum leptin. This correlation between GCR mRNA and serum leptin was negative, which is in accordance with the fact that these two systems have significant and opposite effects on the weight and especially the fat weight.

The serum cortisol was increased with the weight of the subjects, but the reduced lymphocyte GCR mRNA level was probably not due to downregulation due to increased concentrations of cortisol in plasma. Cortisol was not correlated to the waist-hip ratio, serum leptin or lymphocyte GCR mRNA concentrations. Furthermore, it has been reported that the lymphocyte GCR number was unchanged in patients with Cushing's syndrome, who have high levels of cortisol.7

The GCR mRNA concentration may not directly reflect the concentration of the GCR protein in lymphocytes. Previous studies in our laboratory have indicated, however, that transcriptionally mediated changes in the oxytocin receptor and the beta2-adrenoceptor mRNA concentrations in rats were closely correlated to corresponding changes in receptor number and in biological responses.4,5,8 Preferably, we should have measured the concentration of the GCR protein by Western blotting, but the reproducibility of this technique is considerably less than that of the RT-PCR-HPLC technique. This will be attempted, however, on samples from obese subjects, where we expect to find much larger variations in the GCR mRNA content than in the group of normal subjects examined here. The mechanism of the decreased lymphocyte GCR mRNA in the subjects with the highest waist-hip ratio and the highest serum leptin values remains to be elucidated, and it is unclear at present if leptin may inhibit the transcription rate of the GCR mRNA. Leptin has been reported to decrease cortisol secretion.9

We found no correlation between the c-fos mRNA level and changes in GCR mRNA, suggesting that the decreased GCR level was not mediated by cytokines.

The beta2-adrenoceptor mRNA was not related to the GCR mRNA or serum leptin concentrations. Previous studies from our laboratory have indicated that the concentration of lymphocyte beta2-adrenoceptor mRNA was dependent on the lymphocyte subset composition. No differences were demonstrated between normal subjects or obese subjects as regards the beta2-adrenoceptor mRNA level and the subset composition.10

In conclusion, we have shown that the lymphocyte GCR mRNA concentration and serum leptin concentrations are inversely correlated and both of them related to the waist-hip ratio in a group of normal non-obese subjects. It is suggested that the decrease in GCR mRNA concentration with increasing serum leptin concentrations is a counter-regulatory response to an increased body fat content. Further studies are warranted, however, especially to elucidate the relationship between GCR mRNA in lymphocytes and in fat cells and to clarify the mechanism of the decrease in GCR mRNA.

Acknowledgements

The authors wish to thank laboratory technicians Gurli Habekost, Karen Andersen and Inger Hansen for excellent technical assistance.

References

1 Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999; 130: 671-680. MEDLINE

2 Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. Obesity, diabetes and the central nervous system. Diabetologia 1998; 41: 863-881. Article MEDLINE

3 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Engl J Med 1996; 334: 292-295. MEDLINE

4 Engstrøm T, Bratholm P, Vilhardt H, Christensen NJ. Effect of pregnancy on rat myometrial beta2-adrenoceptor mRNA and isoproterenol-induced relaxation of isolated uterine strips. J Endocrinol 1997; 153: 393-399. MEDLINE

5 Engstrøm T, Bratholm P, Vilhardt H, Christensen NJ. beta2-adrenoceptor desensitization in non-pregnant estrogen-primed rat myometrium involves modulation of oxytocin receptor gene expression. J Mol Endocrinol 1998; 20: 261-270. MEDLINE

6 Faure C, Gouhier C, Langer SZ, Graham D. Quantification of alpha-1-adrenoceptor subtypes in human tissues by competitive RT-PCR analysis. Biochem Biophys Res Commun 1995; 213: 935-943. MEDLINE

7 Junker K. Glucocorticoid receptors of human mononuclear leucocytes in vitro. J Clin Endocr Metab 1983; 57: 506-512. MEDLINE

8 Engstrøm T, Bratholm P, Vilhardt H, Christensen NJ. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats. Biol Reprod 1999; 60: 322-329. MEDLINE

9 Glasow A, Haidan A, Hilbers U, Breidert M, Gillespie J, Scherbaum WA, Chrousos GP, Bornstein SR. Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin. J Clin Endocr Metab 1998; 83: 4459-4466. MEDLINE

10 Søndergaard SB, Verdich C, Astrup A, Bratholm P, Christensen NJ. Obese male subjects showed increased resting forearm venous plasma noradrenaline concentration but decreased 24 h sympathetic activity as evaluated by thrombocyte noradrenaline measurements. Int J Obes Relat Metab Disord 1999; 23: 810-815. MEDLINE

Figures

Figure 1 The relationship between serum leptin (ng/ml) and the lymphocyte GCR mRNA concentration (amol/mug total RNA). Results were obtained in 15 normal-weight subjects.

Figure 2 The relationship between the waist-hip ratio and the lymphocyte GCR mRNA concentration (amol/mug total RNA).

Tables

Table 1 Amounts of internal standard added to PCR and annealing temperatures

Table 2 Pertinent clinical data (mean±s.e.m.; n=15)

Table 3 Hormonal and RNA results (mean±s.e.m.; n=15)

Received 27 September 1999; revised 10 January 2000; accepted 3 March 2000
July 2000, Volume 24, Number 7, Pages 915-919
Table of contents    Previous  Article  Next    [PDF]
Privacy Policy © 2000 Nature Publishing Group